skip to Main Content

David Rubin, MD, FACG

David T. Rubin, MD, FACG, is the Joseph B. Kirsner Professor of Medicine, Chief for the Section of Gastroenterology, Hepatology, and Nutrition, and Co-Director of the Digestive Disease Center at the University of Chicago in Illinois. He also currently serves as an associate faculty member at the Maclean Center for Clinical Medical Ethics and an associate investigator at the University of Chicago Comprehensive Cancer Center.

Dr. Rubin earned his medical degree with honors from the University of Chicago Pritzker School of Medicine and completed his residency in internal medicine and fellowships in gastroenterology and clinical medical ethics at the University of Chicago, where he served as Chief Resident and Chief Fellow. He is a Fellow of the American Gastroenterology Association (AGA), American College of Gastroenterology (ACG), American Society for Gastrointestinal Endoscopy (ASGE), and American College of Physicians (ACP), and is an active national member of the Crohn’s & Colitis Foundation of America (CCFA).

Among numerous awards and honors, Dr Rubin was chosen by his peers as a member of Best Doctors (recognized for superior clinical ability) and America’s Top Physicians (gastroenterology). Additionally, he twice received the ACG’s Governor’s Award of Excellence in Clinical Research, the Cancer Research Foundation Young Investigator’s Award, and the UC Postgraduate Teaching Award in recognition of significant contributions for fellowship education. In 2012, he received the CCFA’s Rosenthal Award, a national leadership award bestowed upon a volunteer who has contributed in an indisputable way to the quality of life of patients and families.

Dr. Rubin is the editor of a best-selling book on inflammatory bowel disease (IBD), now in its second edition, and an author or coauthor of many peer-reviewed articles on IBD, genetic testing in IBD, and cancer in IBD. He is also a featured media contact for issues related to IBD, appearing on satellite radio, television, and print media. His principal research interests include novel IBD therapies and outcomes, colon cancer prevention, and clinical medical ethics.

Back To Top